Hainan Poly Pharm Co Ltd (300630) — Capital Reinvestment Ratio

Latest as of June 2023: 4.22x

Hainan Poly Pharm Co Ltd (300630) has a Capital Reinvestment Ratio of 4.22x as of June 2023, meaning it reinvests 4% of its operating cash flow (CN¥44.82 Million) in capital expenditures (CN¥189.19 Million). Check Hainan Poly Pharm Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

4.22x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥44.82 Million
CNY

Capital Expenditures

CN¥189.19 Million
CNY

Data as of

Jun 2023
Most recent filing

Hainan Poly Pharm Co Ltd Capital Reinvestment Ratio (2016–2023)

This chart tracks Hainan Poly Pharm Co Ltd's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see Hainan Poly Pharm Co Ltd (300630) cash conversion ratio.

Annual Capital Reinvestment Ratio for Hainan Poly Pharm Co Ltd (2016–2023)

Year-by-year Capital Reinvestment Ratio for Hainan Poly Pharm Co Ltd from 2016 to 2023. See Hainan Poly Pharm Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2023 4.86x CN¥112.72 Million CN¥548.15 Million ▲ +150.6%
2022 1.94x CN¥534.29 Million CN¥1.04 Billion ▼ -62.1%
2021 5.12x CN¥157.03 Million CN¥803.78 Million ▲ +103.2%
2020 2.52x CN¥332.08 Million CN¥836.54 Million ▲ +34.8%
2019 1.87x CN¥215.37 Million CN¥402.51 Million ▼ -29.7%
2018 2.66x CN¥94.79 Million CN¥251.99 Million ▲ +42.8%
2017 1.86x CN¥93.79 Million CN¥174.58 Million ▲ +13.3%
2016 1.64x CN¥55.53 Million CN¥91.19 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow